After performing DNA sequencing and bioinformatics analysis on the 30 positive clones, we conducted additional screening using SEREX technology to detect high titers of anti-CNN2 autoantibodies in the serum of HCC patients, suggesting that CNN2 may be a novel HCC-associated antigen [14,15]. The gene discussed is CNN2; the disease is hepatocellular carcinoma.